Sander van Deventer

CIK 1543084 · EVP, Research & Product Dev. · last filed 2020-10-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.97M

Companies

3

Total Filings

25

Lifetime Open-Market Net

$693

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
HOOK	Director	2,485	$1.15	$2.9K	$0	4	2020-10-23
QURE	EVP, Research & Product Dev.	71,458	$27.57	$1.97M	-$290.6K	10	2020-03-02
ARGOS THERAPEUTICS INC (ARGS) Delisted	Director	6,205,018	—	—	$291.3K	11	2017-01-20

Recent Filings · Page 3 of 3

25 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-04-04	ARGOS THERAPEUTICS INC (ARGS) Delisted	Grant (A)	+1,367	$0	EDGAR
2016-03-16	ARGOS THERAPEUTICS INC (ARGS) Delisted	Buy (P)	+881,745	$0	EDGAR
2015-06-19	ARGOS THERAPEUTICS INC (ARGS) Delisted	Grant (A)	—	$0	EDGAR
2014-03-24	ARGOS THERAPEUTICS INC (ARGS) Delisted	Grant (A)	—	$0	EDGAR
2014-02-12	ARGOS THERAPEUTICS INC (ARGS) Delisted	Mixed	+2,450,144	$291.3K	EDGAR

Showing 21–25 of 25

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.